ArticlePCN reports : psychiatry and clinical neurosciences2025
Psychometric properties of the Japanese version of the Demoralization Scale-II (DS-II) in cancer patients.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychometric properties of the Japanese version of the Demoralization Scale-II (DS-II) in cancer patients.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Demoralization, which is characterized by helplessness, hopelessness, and the loss of meaning, has gained increasing attention in psychiatry and palliative care. Robinson et al. developed the Demoralization Scale-II (DS-II) to assess this construct in a brief and reliable format. However, a validated Japanese version has not been developed to date. The purpose of this study was to develop a Japanese version of the DS-II (DS-II-J) and to evaluate its psychometric properties in cancer patients. Methods: A total of 147 cancer patients from 3 acute care hospitals in Japan were included in the study. Participants completed the DS-II-J, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item Scale (GAD-7), and Edmonton Symptom Assessment System Revised Version (ESAS-r). Internal consistency was assessed using Cronbach's Results: The DS-II-J demonstrated high internal consistency ( Conclusion: The DS-II-J is a valid and reliable tool for assessing demoralization in Japanese cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.